Elevation Spine is described in the filing as the leading innovator of integrated-fixation spinal technologies and markets a proprietary Saber® Technology platform. Its core product referenced in the article is the Saber-C® system. The company plans to use proceeds from its recent financing to ramp commercial production of Saber-C and to support product development of future Saber Technology extensions. Management said the funding will allow the company to build out a full commercial team and expand use of the Saber-C system. Investors and TVP leadership highlighted that Saber Technology allows surgeons to access hard-to-reach areas of the spine more easily and with fewer procedural steps. Elevation Spine directs readers to its website for more information.

Total raised

$11M

Funding rounds

1

Latest round

Series B

Latest activity

Sep 2022